- Home
- IMMP vs LOCO Comparison
IMMP vs LOCO Comparison
Compare IMMP & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- LOCO
- Stock Information
- Founded
- IMMP 1987
- LOCO 1980
- Country
- IMMP Australia
- LOCO United States
- Employees
- IMMP N/A
- LOCO N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- LOCO Restaurants
- Sector
- IMMP Health Care
- LOCO Consumer Discretionary
- Exchange
- IMMP Nasdaq
- LOCO Nasdaq
- Market Cap
- IMMP 211.1M
- LOCO 270.4M
- IPO Year
- IMMP N/A
- LOCO 2014
- Fundamental
- Price
- IMMP $1.86
- LOCO $9.01
- Analyst Decision
- IMMP Buy
- LOCO Buy
- Analyst Count
- IMMP 2
- LOCO 3
- Target Price
- IMMP $8.50
- LOCO $15.50
- AVG Volume (30 Days)
- IMMP 648.0K
- LOCO 261.3K
- Earning Date
- IMMP 05-16-2025
- LOCO 05-01-2025
- Dividend Yield
- IMMP N/A
- LOCO N/A
- EPS Growth
- IMMP N/A
- LOCO 6.54
- EPS
- IMMP N/A
- LOCO 0.86
- Revenue
- IMMP $3,019,249.00
- LOCO $476,032,000.00
- Revenue This Year
- IMMP $11.25
- LOCO $6.38
- Revenue Next Year
- IMMP $10.22
- LOCO $1.74
- P/E Ratio
- IMMP N/A
- LOCO $10.41
- Revenue Growth
- IMMP 24.11
- LOCO 1.22
- 52 Week Low
- IMMP $1.32
- LOCO $8.29
- 52 Week High
- IMMP $3.34
- LOCO $14.25
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- LOCO 37.33
- Support Level
- IMMP $1.44
- LOCO $8.79
- Resistance Level
- IMMP $2.71
- LOCO $9.55
- Average True Range (ATR)
- IMMP 0.17
- LOCO 0.31
- MACD
- IMMP 0.05
- LOCO -0.02
- Stochastic Oscillator
- IMMP 29.75
- LOCO 47.68
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.